Khushali Jhaveri, Haematology-Oncology Fellow at Moffitt Cancer Centre, shared an article on X:
“Hot off the press:
A lesser-known vulnerability in CAR T-cell therapy: Sarcopenia.
New in CCR AACR.
- Predicts ↑ NRM.
- 1/3 patients lose >10% muscle by D30.
- Linked to fatty acid catabolism.
With Michael Jain, Kai Rejeski, MariSubklewe, Frederick L. Locke.”
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma.
Authors: Khushali Jhaveri, et al.
